missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human Lymphotoxin alpha1/beta2 Protein
Description
The Recombinant Human Lymphotoxin alpha1/beta2 Protein is derived from HEK293. The Recombinant Human Lymphotoxin alpha1/beta2 Protein has been validated for the following applications: Bioactivity.
Specifications
Specifications
| For Use With (Application) | Bioactivity |
| Gene ID (Entrez) | 4049 |
| Molecular Weight (g/mol) | Observed M.W.: 65-76kDa, reducing conditions, Theoretical M.W.: 61kDa |
| Quantity | 25 μg |
| Source | Human embryonic kidney cell,HEK293-derived human Lymphotoxin protein, (N-terminus) rhLT alpha (Leu35-Leu205) Accession &Num; P01374 GGGGS rhLT beta (Gln49-Gly244) Accession &Num; Q06643 GGGGS rhLT beta (Gln49-Gly244) Accession &Num; Q06643 (C-terminus) |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. |
| Endotoxin Concentration | <0.10 EU per 1μg of the protein by the LAL method. |
| Common Name | Lymphotoxin |
| Gene Symbol | LTA |
| Biological Activity | Measured by its ability to induce IL-8 secretion by A375 human melanoma cells. The ED50 for this effect is typically 3-15ng/mL. |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?